Who owns TherapeuticsMD Inc?
- Ticker: TXMD
- CUSIP Number: 88338n206
Tip: Access positions for across all investors
Analyze quarterly positions in TherapeuticsMD with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of TherapeuticsMD stock
Who bought or sold TherapeuticsMD Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Rubric Capital Management | 1.2M | $1.9M | 0% | Dec 2025 |
|
| Clearline Capital | 635k | $1.0M | 0% | Dec 2025 |
|
| Vanguard Group | 397k | $647k | 5% | Dec 2025 |
|
| Tejara Capital | 351k | $572k | 2% | Dec 2025 |
|
| ADAR1 Capital Management | 209k | $341k | 0% | Dec 2025 |
|
| BlackRock | 116k | $189k | 0% | Dec 2025 |
|
| Geode Capital Management | 106k | $173k | -3% | Dec 2025 |
|
| Renaissance Technologies | 97k | $157k | 172% | Dec 2025 |
|
| Susquehanna International | 59k | $97k | 100% | Dec 2025 |
|
| Citadel Advisors | 49k | $80k | 43% | Dec 2025 |
|
| State Street Corporation | 30k | $49k | 0% | Dec 2025 |
|
| Bridgeway Capital Management | 17k | $28k | -50% | Dec 2025 |
|
| Northern Trust | 16k | $27k | 0% | Dec 2025 |
|
| Jane Street | 12k | $20k | 100% | Dec 2025 |
|
| Advisor Group Holdings | 9.3k | $15k | 936% | Dec 2025 |
|
| FMR | 8.3k | $14k | 0% | Dec 2025 |
|
| Tower Research Capital | 2.5k | $4.0k | -10% | Dec 2025 |
|
| Group One Trading | 1.6k | $2.6k | 100% | Dec 2025 |
|
| UBS Group | 1.1k | $1.8k | 208% | Dec 2025 |
|
| National Bank Of Canada /fi/ | 610.00 | $976.000000 | -9% | Dec 2025 |
|
| Smartleaf Asset Management | 601.00 | $986.000600 | 100% | Dec 2025 |
|
| SBI Securities | 255.00 | $416.007000 | 0% | Dec 2025 |
|
| Us Bancorp | 246.00 | $401.004600 | 0% | Dec 2025 |
|
| Bnp Paribas Arbitrage, Snc | 226.00 | $367.995800 | 0% | Dec 2025 |
|
| Huntington National Bank | 120.00 | $195.996000 | 0% | Dec 2025 |
|
| Activest Wealth Management | 40.00 | $81.000000 | 0% | Mar 2026 |
|
| Wells Fargo & Company | 37.00 | $59.999200 | 0% | Dec 2025 |
|
| Steward Partners Investment Advisory | 35.00 | $57.001000 | 0% | Dec 2025 |
|
| Farther Finance Advisors | 31.00 | $62.000000 | 3% | Mar 2026 |
|
| IFP Advisors | 21.00 | $42.000000 | 0% | Mar 2026 |
|
| CWM | 20.00 | $0 | 0% | Dec 2025 |
|
| Provenance Wealth Advisors | 20.00 | $40.000000 | 0% | Mar 2026 |
|
| Atlantic Trust | 20.00 | $33.000000 | 100% | Dec 2025 |
|
| Truvestments Capital | 10.00 | $16.000000 | 0% | Dec 2025 |
|
| Harbour Investments | 8.00 | $13.000000 | 0% | Dec 2025 |
|
| Banque Cantonale Vaudoise | 7.00 | $0 | 0% | Mar 2026 |
|
| Assetmark | 4.00 | $7.000000 | 0% | Dec 2025 |
|
| Smallwood Wealth Investment Management | 2.00 | $3.000000 | 0% | Dec 2025 |
|
| Strategic Advocates | 1.00 | $2.000000 | 0% | Dec 2025 |
|
| EverSource Wealth Advisors | 1.00 | $2.000000 | 0% | Dec 2025 |
|
Who sold out of TherapeuticsMD?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| J. Goldman & Co | Sep 2025 | 14k | $15k |
| Two Sigma Securities | Sep 2025 | 12k | $13k |
| Barclays | Sep 2025 | 44.00 | $47.000800 |
| Wealth Watch Advisors | Sep 2025 | 22.00 | $23.999800 |
| Advisory Services Network | Sep 2025 | 14.00 | $14.999600 |
| Goss Wealth Management | Sep 2025 | 1.00 | $1.000000 |